Behrenbruch Christian
SEC CIK 2037713 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TLX | Telix Pharmaceuticals Ltd | MD, Group CEO, Dir | 20.74M | $996.7K | — | 1 | 2026-04-28 | 2026-04-28 |
Most active insiders at TLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Behrenbruch Christian | MD, Group CEO, Dir | $996.7K | — |
| 2 | Smith Darren Charlton | Group CFO | $20.0K | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-05-06 21:32 | 2026-04-28+ | TLX | Telix Pharmaceuticals Ltd | Behrenbruch Christian | MD, Group CEO, Dir | P - Purchase | $14.67 | +67.9K | 20.74M | +0.3% | +$996.7K |
Purchase Sale Sale after option exercise All abbreviations